Coherus Oncology, Inc. (CHRS) › EPS (Basic)Coherus Oncology, Inc. (CHRS) — EPS (Basic)Annual figures by period end, from SEC filings.2017-12-31: $-4.482018-12-31: $-3.222019-12-31: $1.292020-12-31: $1.852021-12-31: $-3.812022-12-31: $-3.762023-12-31: $-2.532024-12-31: $0.252025-12-31: $1.43$1.432017-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$1.43+472.0%2026-03-09From 2025-01-012024-12-31$0.25—2026-03-09From 2024-01-012023-12-31$-2.53—2025-03-17From 2023-01-012022-12-31$-3.76—2025-03-17From 2022-01-012021-12-31$-3.81-305.9%2024-03-15From 2021-01-012020-12-31$1.85+43.4%2023-03-06From 2020-01-012019-12-31$1.29—2022-02-23From 2019-01-012018-12-31$-3.22—2021-02-25From 2018-01-012017-12-31$-4.48—2020-02-27From 2017-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares